PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

"Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30

2025-08-14
(Press-News.org) "Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30 days later.

+++

Article URL: https://plos.io/411ECQu

Article Title: A performing arts intervention to decrease suicide stigma on campus: A three time point assessment of “Every Brilliant Thing”

Author Countries: United States

Funding: The authors received no specific funding for this work.

END


ELSE PRESS RELEASES FROM THIS DATE:

Climate models reveal human influence behind stalled pacific cycle

2025-08-14
A new CU Boulder-led study has revealed that recent changes in North Pacific Ocean temperatures—long believed to be the result of natural variability—are in fact being driven by human-generated greenhouse gas and industrial aerosol emissions. These oceanic shifts are directly linked to the prolonged megadrought gripping the American Southwest, and this research published August 13th in Nature suggests it may not ease for another 30 years. “Our results show that the drought and ocean patterns we’re seeing today are not just natural fluctuations—they’re largely driven by human activity,” ...

Laying the foundation for gene editing for inherited progressive deafness in adults, DFNA41

2025-08-14
Zheng-Yi Chen, DPhil, associate scientist at the Eaton-Peabody Laboratories, and Ines and Fredrick Yeatts Chair in Otolaryngology, at Mass Eye and Ear, is the senior and co-corresponding author of a paper published in the Journal of Clinical Investigation, “Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness.” Q: How would you summarize your study for a lay audience? This study provides an example of a successful use of gene editing technology to treat a mouse model of human genetic hearing loss. We developed a one-time, gene editing ...

Monell Center researchers present latest findings at International Meeting on Consumer Sensory Science

2025-08-14
Monell Center Researchers Present Latest Findings at International Meeting On Consumer Sensory Science Coinciding with the 2025 Philadelphia-based conference, Monell - the first independent nonprofit dedicated to smell and taste research - hosts academic, industry partners for visits, collaborations  PHILADELPHIA (Aug 14, 2025) – Scientists from the Monell Chemical Senses Center will present their research at the 16th Pangborn Sensory Science Symposium, “Connecting Senses and Minds,” August 17-21, 2025 ...

AFAR receives NIH award renewal totaling more than $5.7 million for the Nathan Shock Centers Coordinating Center

2025-08-14
NEW YORK — The American Federation for Aging Research (AFAR) has received a five-year renewal award totaling $5,722,435 from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to continue and expand the Nathan Shock Centers Coordinating Center (NSC3). The NSC3 coordinates the activities of the 8 Nathan Shock Centers (NSC) of Excellence in the Basic Biology of Aging, which provide expert resources to expand basic research into the biology of aging. The NSCs began in 1995 in honor of ...

Brain-computer interface could decode inner speech in real time

2025-08-14
Scientists have pinpointed brain activity related to inner speech—the silent monologue in people’s heads—and successfully decoded it on command with up to 74% accuracy. Publishing August 14 in the Cell Press journal Cell, their findings could help people who are unable to audibly speak communicate more easily using brain-computer interface (BCI) technologies that begin translating inner thoughts when a participant says a password inside their head.  “This is the first time ...

Cancer drug eliminates aggressive cancers in clinical trial

2025-08-14
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously systemic inflammatory responses, low platelet counts, and liver toxicity, among other adverse reactions—even at a low dose. But in 2018, the lab of Rockefeller University’s Jeffrey V. Ravetch demonstrated it could engineer an enhanced CD40 ...

Ancient cephalopod, new insight: Nautilus reveals unexpected sex chromosome system

2025-08-14
Nautiloids—a lineage of ancient, externally-shelled cephalopods that diverged from their octopus and squid relatives over 400 million years ago—once dominated our oceans. Today, this living fossil is restricted to a handful of species in the Southern Indo-Pacific, making it one of the few marine invertebrates listed under CITES appendix II of species in need of protection from over-exploitation.. Although no one had previously investigated sex determination systems in cephalopods, recent research suggested a ZZ/Z0 ...

MIT researchers use generative AI to design compounds that can kill drug-resistant bacteria

2025-08-14
CAMBRIDGE, MA -- With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research team designed more than 36 million possible compounds and computationally screened them for antimicrobial properties. The top candidates they discovered are structurally distinct from any existing antibiotics, and they appear to work by novel ...

Alzheimer’s disease pathology and potential treatment targets identified in brain organoids

2025-08-14
Alzheimer's disease (AD) is the most common neurodegenerative disease in older people, affecting up to 1 in 20 individuals aged 65 and above. In addition to environmental and lifestyle factors, genetic mutations can predispose an individual to AD and some rare forms of inherited “familial” AD (fAD) are caused by known genetic mutations, with these affected individuals developing AD with high probability and at relatively young age. In most cases, AD is diagnosed at advanced stages, but pathological alterations in brain cells may ...

1 in 3 US adults unaware of connection between HPV and cancers

2025-08-14
The human papillomavirus (HPV) can cause six types of cancer.  It’s responsible for almost all cervical cancer cases. HPV now causes the majority of oropharyngeal (throat) cancers. It can also cause anal, vaginal, vulvar and penile cancers.   Yet new analysis from researchers at MUSC Hollings Cancer Center shows that most people are unaware of the connection between HPV and all of these cancers.   That awareness is critical, said lead researcher Kalyani Sonawane, Ph.D., because it informs people’s decisions ...

LAST 30 PRESS RELEASES:

Interaction of climate change and human activity and its impact on plant diversity in Qinghai-Tibet plateau

From addressing uncertainty to national strategy: an interpretation of Professor Lim Siong Guan’s views

Clinical trials on AI language model use in digestive healthcare

Scientists improve robotic visual–inertial trajectory localization accuracy using cross-modal interaction and selection techniques

Correlation between cancer cachexia and immune-related adverse events in HCC

Human adipose tissue: a new source for functional organoids

Metro lines double as freight highways during off-peak hours, Beijing study shows

Biomedical functions and applications of nanomaterials in tumor diagnosis and treatment: perspectives from ophthalmic oncology

3D imaging unveils how passivation improves perovskite solar cell performance

Enriching framework Al sites in 8-membered rings of Cu-SSZ-39 zeolite to enhance low-temperature ammonia selective catalytic reduction performance

AI-powered RNA drug development: a new frontier in therapeutics

Decoupling the HOR enhancement on PtRu: Dynamically matching interfacial water to reaction coordinates

Sulfur isn’t poisonous when it synergistically acts with phosphine in olefins hydroformylation

URI researchers uncover molecular mechanisms behind speciation in corals

Chitin based carbon aerogel offers a cleaner way to store thermal energy

Tracing hidden sources of nitrate pollution in rapidly changing rural urban landscapes

Viruses on plastic pollution may quietly accelerate the spread of antibiotic resistance

Three UH Rainbow Babies & Children’s faculty elected to prestigious American Pediatric Society

Tunnel resilience models unveiled to aid post-earthquake recovery

Satellite communication systems: the future of 5G/6G connectivity

Space computing power networks: a new frontier for satellite technologies

Experiments advance potential of protein that makes hydrogen sulfide as a therapeutic target for Alzheimer’s disease

Examining private equity’s role in fertility care

Current Molecular Pharmacology achieves a landmark: real-time CiteScore advances to 7.2

Skeletal muscle epigenetic clocks developed using postmortem tissue from an Asian population

Estimating unemployment rates with social media data

Climate policies can backfire by eroding “green” values, study finds

Too much screen time too soon? A*STAR study links infant screen exposure to brain changes and teen anxiety

Global psychiatry mourns Professor Dan Stein, visionary who transformed mental health science across Africa and beyond

KIST develops eco-friendly palladium recovery technology to safeguard resource security

[Press-News.org] "Every Brilliant Thing”, the interactive one-person play with a suicidality theme now making its West End debut, reduced suicide-associated stigma among university students who attended, even up to 30